Recent News

Biomarker CD47 as a Successful Diagnostic and Treatment Tool

March 13, 2018

Survival rates for diffuse mesothelioma are notoriously low with the median survival ranging between 12 to 22 months.  A contributing factor to treatment being ineffective is that the disease if[…]

Read More

Epithelioid Mesothelioma And Reactive Mesothelial Hyperplasia

March 5, 2018

The type of mesothelioma can be based upon where the cancer is located in the body, but it can also be based upon cell type – meaning, which cell has[…]

Read More

Asbestos Cancer Risk Measured by Fiber Length

March 2, 2018

Since asbestos was used for decades in thousands of products ranging from attic insulation to woven oven mitts, it is hard to imagine that this versatile material is actually a naturally occurring[…]

Read More

Asbestos Regulations – National Cancer Prevention Month

February 23, 2018

Despite the known dangers of asbestos exposure, asbestos is still legal in the United States. However, it is heavily regulated within different organizations in the government. Different agencies have their[…]

Read More

Clinical Trial Investigates Multimodality Treatment for Pleural and Peritoneal Mesothelioma

February 15, 2018

Researchers at the Memorial Sloan Kettering Cancer Center are collaborating with Pfizer to study the effects of immunotherapy treatment Avelumab when combined with stereotactic body radiation therapy, or SBRT, for[…]

Read More

Effective Chemotherapy May Rest Upon Reducing Overactive Enzyme

February 6, 2018

Chemotherapy for mesothelioma patients has been notoriously difficult and the cancer continues to be overwhelmingly unresponsive to such treatment in many cases. However, researchers and scientists have been continually investigating[…]

Read More

February is National Cancer Prevention Month

February 1, 2018

Cancer is the second most leading cause of death in the United States affecting over 500,000 people. However, is estimated that 1/3 of all cancers could be prevented through daily[…]

Read More

The Orphan Drug Act and the National Organization for Rare Disorders Bring Attention and Funding to Rare Diseases

January 25, 2018

Testing and developing new drugs and treatments for an illness is a costly endeavor, but drug companies thrive in this business by being able to sell medication to the sick[…]

Read More

Gene Therapy and DNA Sequencing for Malignant Mesothelioma

January 19, 2018

Genes are the basic unit of DNA that creates unique proteins used for specific cellular function. The expression of that gene creates an effect and if a gene cannot make[…]

Read More

Multimodality Therapy in Pleural Mesothelioma

January 11, 2018

Even though there is no cure for mesothelioma, there are many different treatment options for those suffering from this almost always fatal cancer. Palliative therapy has been successful in lessening[…]

Read More